Barth P - Search Results

1

In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.

Olbert PJ, Schrader AJ, Simon C, Dalpke A, Barth P, Hofmann R, Hegele A. Olbert PJ, et al. Among authors: barth p. Anticancer Res. 2009 Jun;29(6):2067-76. Anticancer Res. 2009. PMID: 19528466 Free article.

2

Immunostimulatory CpG oligonucleotides reduce tumor burden after intravesical administration in an orthotopic murine bladder cancer model.

Hegele A, Dalpke A, Heeg K, Barth P, Varga Z, Hofmann R, Olbert P. Hegele A, et al. Among authors: barth p. Tumour Biol. 2005 Sep-Oct;26(5):274-80. doi: 10.1159/000087380. Epub 2005 Aug 9. Tumour Biol. 2005. PMID: 16103747

3

Antineoplastic effect of immunostimulatory DNA (CpG-ODN) in a murine C57-BL6/MB-49 transitional cell carcinoma model.

Hegele A, Dalpke A, Barth P, Varga Z, Heeg K, Hofmann R, Olbert P. Hegele A, et al. Among authors: barth p. Anticancer Res. 2004 Jul-Aug;24(4):2225-30. Anticancer Res. 2004. PMID: 15330165 Free article.

4

CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings.

Hegele A, Mecklenburg V, Varga Z, Olbert P, Hofmann R, Barth P. Hegele A, et al. Among authors: barth p. Anticancer Res. 2010 Dec;30(12):5195-200. Anticancer Res. 2010. PMID: 21187512

5

[CpG-ODN instillation boosts ICAM-1 expression in an orthotopic murine UCC model: immunohistochemical evaluation of the local response to immunostimulatory DNA].

Klebe M, Olbert PJ, Hofmann R, Barth PJ, Hegele A. Klebe M, et al. Aktuelle Urol. 2024 Apr;55(2):154-160. doi: 10.1055/a-1268-2069. Epub 2021 Apr 14. Aktuelle Urol. 2024. PMID: 33853160 German.

6

Localization of FOXP3-positive cells in renal cell carcinoma.

Sell K, Barth PJ, Moll R, Thomas MA, Zimmer N, Oplesch E, Gudo M, Schrader M, Hofmann R, Schrader AJ. Sell K, et al. Tumour Biol. 2012 Apr;33(2):507-13. doi: 10.1007/s13277-011-0283-1. Epub 2011 Dec 6. Tumour Biol. 2012. PMID: 22143939

7

Accuracy of frozen section examination of testicular tumors of uncertain origin.

Elert A, Olbert P, Hegele A, Barth P, Hofmann R, Heidenreich A. Elert A, et al. Among authors: barth p. Eur Urol. 2002 Mar;41(3):290-3. doi: 10.1016/s0302-2838(02)00004-0. Eur Urol. 2002. PMID: 12180230

8

The prognostic impact of Claudin 6 in papillary renal cell carcinoma.

Mikuteit M, Zschäbitz S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Steffens S, Erlmeier F. Mikuteit M, et al. Among authors: barth p. Pathol Res Pract. 2022 Mar;231:153802. doi: 10.1016/j.prp.2022.153802. Epub 2022 Feb 11. Pathol Res Pract. 2022. PMID: 35180650

9

Genetic pathways and new progression markers for prostate cancer suggested by microsatellite allelotyping.

von Knobloch R, Konrad L, Barth PJ, Brandt H, Wille S, Heidenreich A, Moll R, Hofmann R. von Knobloch R, et al. Clin Cancer Res. 2004 Feb 1;10(3):1064-73. doi: 10.1158/1078-0432.ccr-03-0070. Clin Cancer Res. 2004. PMID: 14871986

10

CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder.

Nimphius W, Moll R, Olbert P, Ramaswamy A, Barth PJ. Nimphius W, et al. Among authors: barth pj. Virchows Arch. 2007 Feb;450(2):179-85. doi: 10.1007/s00428-006-0347-6. Virchows Arch. 2007. PMID: 17149610

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

682 results

Search Page

Filters